EA
ACIU icon

Emerald Acquisition’s AC Immune ACIU Stock Holding History

Emerald Acquisition’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$288K Buy
+17,500
New +$302K ﹤0.01% 2612

Other funds holding ACIU

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Emerald Acquisition's ACIU Position: Q3 2016 in Review

Emerald Acquisition opened a new position in AC Immune (ACIU) in Q3 2016: 17,500 shares worth $288K. The stake represents ﹤0.01% of the portfolio and ranks #2612 among its holdings.

31 funds tracked by Wall St. Rank hold ACIU as of Q3 2016.

  • Emerald Acquisition held 17,500 shares of AC Immune worth $288K as of Q3 2016.
  • AC Immune was a new Emerald Acquisition position in Q3 2016.
  • AC Immune made up ﹤0.01% of Emerald Acquisition's portfolio in Q3 2016, its #2612 holding.
  • 31 funds tracked by Wall St. Rank held AC Immune as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.